tiprankstipranks
Trending News
More News >
American Healthcare REIT, Inc. (AHR)
NYSE:AHR
US Market
Advertisement

American Healthcare REIT, Inc. (AHR) AI Stock Analysis

Compare
192 Followers

Top Page

AHR

American Healthcare REIT, Inc.

(NYSE:AHR)

Rating:70Neutral
Price Target:
$46.00
▲(7.65% Upside)
American Healthcare REIT, Inc. scores a 69.5, driven by strong earnings call results and positive technical indicators. The company's financial performance is mixed, with strong cash flow but negative profitability metrics. Valuation concerns due to a negative P/E ratio are offset by a reasonable dividend yield. The stock's bullish momentum is tempered by overbought technical indicators, suggesting caution.
Positive Factors
Earnings
The stock price is expected to react positively due to a solid earnings beat and one of the biggest guidance raises this quarter.
Growth Potential
The $300 million acquisition pipeline of deals already awarded to AHR could drive additional growth.
Market Position
AHR is uniquely positioned to outperform over the foreseeable future given its exposure to senior housing RIDEA assets, which are believed to carry some of the best fundamentals in real estate.
Negative Factors
Earnings Report
The income statement published in the earnings press release is missing values for Loss from unconsolidated entities.
Financial Estimates
Lowering FFO Estimates due to recent property dispositions and equity offering.
Financial Performance
1Q total portfolio Same-Store NOI was 15.1% compared to 21.6% in the prior quarter.

American Healthcare REIT, Inc. (AHR) vs. SPDR S&P 500 ETF (SPY)

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company DescriptionFormed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
How the Company Makes MoneyAmerican Healthcare REIT, Inc. generates revenue primarily through leasing its healthcare properties to healthcare providers and operators. The company earns rental income from long-term leases, which are often structured with inflation escalators or rent increases over time. AHR also benefits from property appreciation and capital gains by strategically acquiring and disposing of assets within its portfolio. Additionally, the company may form joint ventures or partnerships with healthcare operators to enhance property management and operational efficiency, further contributing to its earnings.

American Healthcare REIT, Inc. Earnings Call Summary

Earnings Call Date:Aug 07, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 18, 2025
Earnings Call Sentiment Positive
The earnings call presented a strong performance with significant NOI growth, successful acquisitions, and improved financial metrics. Challenges were noted in the outpatient medical segment and potential seasonal slowdowns in Trilogy, but these were overshadowed by positive developments.
Q2-2025 Updates
Positive Updates
Strong NOI Growth
American Healthcare REIT delivered 13.9% total portfolio same-store NOI growth in Q2 2025 compared to the same period in 2024. Trilogy segment saw 18.3% same-store NOI growth year-over-year.
Successful Acquisitions and Pipeline
The company completed approximately $255 million in acquisitions year-to-date and maintains a pipeline of over $300 million in awarded deals.
Leverage Improvement
Net debt to EBITDA improved to 3.7x at the end of Q2 2025 from 4.5x on March 31, 2025.
Increased 2025 Guidance
Full-year 2025 NFFO per share guidance was raised to a range of $1.64 to $1.68 from a previous range of $1.58 to $1.64.
Great Place to Work Certification
American Healthcare REIT was awarded the Great Place to Work Certification, recognizing the company's strong workplace culture.
Medicare Advantage Growth
Trilogy's concentration of Medicare Advantage increased to 7.2% of resident days compared to 5.8% a year ago, contributing to higher revenue per resident day.
Negative Updates
Outpatient Medical Segment Challenges
Outpatient medical segment experienced a guidance range adjustment, reflecting modest growth challenges.
Trilogy Guidance Reflects Seasonal Slowdown
Trilogy's same-store NOI growth guidance indicates a potential slowdown in the second half of the year due to seasonal factors.
Company Guidance
During the American Healthcare REIT's second-quarter 2025 earnings call, the company reported a robust set of results and provided updated guidance reflecting their strong performance. Notably, they delivered a 13.9% growth in total portfolio same-store NOI compared to the same period in 2024 and anticipate sustaining double-digit NOI growth for the rest of the year. Their acquisition strategy has been active, with $255 million in acquisitions closed year-to-date, contributing to a pipeline exceeding $300 million. The REIT plans to continue this momentum, focusing on high-quality long-term care assets. Financially, the company's net debt to EBITDA improved to 3.7x from 4.5x at the end of March 2025. The company raised its full-year 2025 NFFO per share guidance to a range of $1.64 to $1.68, up from $1.58 to $1.64, driven by strong organic growth. The guidance for total same-store NOI growth was also increased to a range of 11% to 14%. Additionally, the REIT's operations team has achieved notable progress in occupancy and rate growth, particularly within their Trilogy segment, which saw a 18.3% increase in same-store NOI year-over-year.

American Healthcare REIT, Inc. Financial Statement Overview

Summary
American Healthcare REIT, Inc. shows mixed financial performance. Revenue growth is steady, and cash flow metrics are strong, indicating good operational cash management. However, profitability remains a concern with negative net income and return on equity. The company has improved its leverage position, but further efforts are needed to enhance profitability and shareholder returns.
Income Statement
65
Positive
The income statement shows a mixed performance. The TTM revenue growth rate is positive at 1.8%, indicating a steady increase in revenue. However, the company is struggling with profitability, as evidenced by a negative net profit margin of -1.53% and a negative net income. The gross profit margin has improved significantly to 39.85% in the TTM, suggesting better cost management. EBIT and EBITDA margins are moderate, indicating operational efficiency but not translating into net profitability.
Balance Sheet
60
Neutral
The balance sheet reflects a moderate financial position. The debt-to-equity ratio has improved to 0.66 in the TTM, indicating a reduction in leverage compared to previous years. However, the return on equity remains negative at -1.43%, highlighting ongoing profitability challenges. The equity ratio is stable, suggesting a balanced asset structure, but the company needs to improve its return metrics to enhance shareholder value.
Cash Flow
70
Positive
Cash flow analysis shows positive trends, with a strong free cash flow growth rate of 34.63% in the TTM, indicating improved cash generation capabilities. The operating cash flow to net income ratio is high at 0.93, suggesting efficient cash conversion from operations. The free cash flow to net income ratio is also robust at 0.79, reflecting good cash flow management despite negative net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.15B2.07B1.86B1.62B1.26B1.18B
Gross Profit443.25M416.77M356.83M335.97M182.01M158.58M
EBITDA289.30M315.48M324.26M233.76M159.43M165.14M
Net Income-32.80M-37.81M-71.47M-81.30M-47.79M2.16M
Balance Sheet
Total Assets4.51B4.49B4.58B4.79B4.58B3.23B
Cash, Cash Equivalents and Short-Term Investments133.49M76.70M43.45M65.05M81.60M113.21M
Total Debt1.60B1.87B2.80B2.83B2.50B1.88B
Total Liabilities2.04B2.18B3.12B3.14B2.75B2.16B
Stockholders Equity2.42B2.26B1.27B1.40B1.58B866.11M
Cash Flow
Free Cash Flow153.09M84.15M-1.26M76.25M-61.78M90.85M
Operating Cash Flow254.73M176.09M98.53M147.77M17.91M219.16M
Investing Cash Flow-38.06M-8.73M9.40M-118.58M-138.65M-147.94M
Financing Cash Flow-144.33M-134.74M-129.06M-42.92M94.11M-8.81M

American Healthcare REIT, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price42.73
Price Trends
50DMA
39.19
Positive
100DMA
36.36
Positive
200DMA
32.30
Positive
Market Momentum
MACD
1.03
Positive
RSI
71.69
Negative
STOCH
55.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Positive. The current price of 42.73 is above the 20-day moving average (MA) of 41.70, above the 50-day MA of 39.19, and above the 200-day MA of 32.30, indicating a bullish trend. The MACD of 1.03 indicates Positive momentum. The RSI at 71.69 is Negative, neither overbought nor oversold. The STOCH value of 55.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AHR.

American Healthcare REIT, Inc. Risk Analysis

American Healthcare REIT, Inc. disclosed 79 risk factors in its most recent earnings report. American Healthcare REIT, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

American Healthcare REIT, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$7.61B28.208.36%3.68%50.84%104.44%
79
Outperform
$3.67B24.6610.49%4.66%6.87%7.23%
74
Outperform
$4.58B24.996.66%6.31%6.89%240.70%
70
Neutral
$7.29B-1.51%2.34%11.62%
61
Neutral
$6.15B-7.59%6.48%-7.16%23.40%
55
Neutral
$6.29B4.66-20.95%6.01%10.84%8.15%
49
Neutral
$2.67B-25.97%6.94%27.66%18.03%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AHR
American Healthcare REIT, Inc.
42.73
21.08
97.37%
NHI
National Health Investors
78.40
-0.23
-0.29%
SBRA
Sabra Healthcare REIT
19.03
2.81
17.32%
MPW
Medical Properties
4.61
-0.13
-2.74%
HR
Healthcare Realty Trust
18.06
1.30
7.76%
CTRE
CareTrust REIT
33.94
5.28
18.42%

American Healthcare REIT, Inc. Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
American Healthcare REIT’s New $1 Billion Equity Offering
Neutral
Aug 8, 2025

On August 8, 2025, American Healthcare REIT, Inc. entered into a new ATM Equity Offering Sales Agreement with several financial institutions, allowing for the sale of up to $1 billion in common stock. This agreement replaces a prior offering program and aims to provide flexibility in raising capital based on market conditions and company needs, potentially impacting the company’s financial strategy and market presence.

Private Placements and FinancingM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
American Healthcare REIT Reports Strong Q2 2025 Results
Positive
Aug 7, 2025

On August 7, 2025, American Healthcare REIT, Inc. announced its second quarter 2025 results, reporting a GAAP net income of $9.9 million and a significant growth in Same-Store Net Operating Income (NOI) of 13.9% compared to the same period in 2024. The company increased its full-year 2025 guidance due to strong performance in its senior housing and integrated senior health campuses segments. The company also completed several acquisitions and sales, including the purchase of a new senior housing operating property for $65 million and issuing shares through its equity offering program, raising substantial capital. These strategic moves are expected to enhance the company’s financial position and support its mission of providing high-quality care.

Shareholder MeetingsBusiness Operations and Strategy
American Healthcare REIT Holds Annual Stockholders Meeting
Neutral
Jun 26, 2025

On June 25, 2025, American Healthcare REIT, Inc. held its Annual Meeting of Stockholders where four key proposals were voted upon. The stockholders elected nine directors for a one-year term, ratified Deloitte & Touche as the independent accounting firm for 2025, approved executive compensation for 2024 on an advisory basis, and approved the 2025 Manager Equity Plan. These decisions reflect the company’s ongoing governance and strategic planning efforts, potentially impacting its operational and financial management in the coming year.

Dividends
American Healthcare REIT Announces Quarterly Distribution
Positive
Jun 20, 2025

On June 20, 2025, American Healthcare REIT, Inc. announced a quarterly distribution of $0.25 per share for the second quarter of 2025, payable on or about July 18, 2025, to shareholders of record as of June 30, 2025. This distribution reflects an annualized rate of $1.00 per share and underscores the company’s commitment to providing returns to its investors, potentially enhancing its attractiveness in the real estate investment sector.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 21, 2025